Yulin Wei

Yulin Wei is an MBA holder, a senior economist, and a qualified pharmacist. His career began at Tianjin Pharmaceutical Center from a position of a salesman and was promoted over the years (1984 to 1999) to Deputy General Manager before assuming the role of Executive Deputy General Manager, Pharmaceutical Company of Development Zone of the Pharmaceutical Department of Tianjin Pharmaceutical Center in the China Pharmaceutical Group.

From 1999 to 2003, Mr. Wei served as the general manager of Tianjin Company of China Pharmaceutical Group before moving on to be the Chief Operating Officer, Executive Deputy General Manager, President, and Chairman of Sinopharm Holding Co., Ltd.

Mr. Wei became the CEO of Sinopharm holding Medical Investment Management Co., Ltd. In 2017. He has won many awards and accolades from the Tianjin, China Pharmaceutical Group Corporation, the Ministry of Human Resources and Social Security of China, and the Shanghai Municipal government successively. One of his proudest accomplishments was winning the Best Business Leader Award of China in 2012 and elected as the best CEO of The Year; as well as The Most Respected Chairman of China’s Listed Companies and The Leader of International Multinational Companies in 2016. In 2019, Mr. Wei was elected as Outstanding Person in the 40th anniversary of Reform and Opening Up of China’s Pharmaceutical Circulation Industry.